<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-04-25T15:43:49Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/2483" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/2483</identifier>
				<datestamp>2024-03-31T05:45:28Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Synthesis and structural depiction of the isomeric benzimidazole pair and  its in-silico anti-SARS-CoV-2 activities</dc:title>
	<dc:creator>Debnath, Ananya</dc:creator>
	<dc:creator>Mahato, Shreya</dc:creator>
	<dc:creator>De, Abhranil</dc:creator>
	<dc:creator>Verma, Himanshu</dc:creator>
	<dc:creator>Silakari, Om</dc:creator>
	<dc:creator>Biswas, Bhaskar</dc:creator>
	<dc:subject xml:lang="en-US">Synthesis</dc:subject>
	<dc:subject xml:lang="en-US">MD simulations</dc:subject>
	<dc:subject xml:lang="en-US">Crystal structure</dc:subject>
	<dc:subject xml:lang="en-US">Molecular docking</dc:subject>
	<dc:subject xml:lang="en-US">Mono-substituted benzimidazole</dc:subject>
	<dc:subject xml:lang="en-US">In silico anti-SARS-COV-2 screening activity</dc:subject>
	<dc:description xml:lang="en-US">The present work presents a straightforward synthesis, spectroscopic and structural depiction, and in silico anti-SARS-CoV-2 activity of an isomeric monosubstituted benzimidazole pair, 2-(1H-benzo[d]imidazol-2-yl)-6-methoxyphenol (L1O) and 4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenol (L1P). The derivatives were synthesized by a coupling of aromatic aldehydes and o-phenylenediamine in ethanol under reflux. Different spectroscopic methods and X-ray structural analysis were employed to characterize the compounds. The crystal structure of L1O reveals that the o-vanillin substituted benzimidazole compound crystallizes in a monoclinic system and adopts a planar geometry. In silico anti-SARS-CoV-2 proficiencies of synthetic derivatives were evaluated against the main protease (Mpro) and nonstructural proteins (nsp2 and nsp7) of SARS-CoV-2. Molecular docking reveals the binding scores for the L1O-Mpro, L1O-nsp2 and L1O-nsp7 complexes as -11.31, -6.06 and -8.13 kcal/mol, respectively, while the binding scores for the L1P-Mpro, L1P-nsp2 and L1P-nsp7 complexes as -10.62, -5.09 and -6.91 kcal/mol, respectively, attributing the excellent conformational stability for both the isomeric benzimidazole derivatives.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2024-03-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>text/plain</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/2483</dc:identifier>
	<dc:identifier>10.5155/eurjchem.15.1.39-49.2483</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 15 No. 1 (2024): March 2024; 39-49</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/2483/2771</dc:relation>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/2483/2772</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Ananya Debnath, Shreya Mahato, Abhranil De, Himanshu Verma, Om Silakari, Bhaskar Biswas</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
